Maxime M. Verhoeven
Utrecht, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
HandScan criteria versus ACR/EULAR Boolean remission as treatment target in early rheumatoid arthritis: results of a randomized controlled trial.
Journal: Rheumatology advances in practice
Published: March 12, 2025
Classification of rheumatoid arthritis into active or inactive with a modified Disease Activity score, for future use as a treat-to-target tool, with a HandScan score replacing joint counts.
Journal: Clinical and experimental rheumatology
Published: July 08, 2021
Unravelling the Cost of Biological Strategies in Rheumatoid Arthritis: A Kaleidoscope of Methodologies, Interpretations, and Interests.
Journal: The Journal of rheumatology
Published: May 16, 2021
A Sex Difference in HandScan Scores in Rheumatoid Arthritis Patients and Controls? An Ongoing Analysis of the Sex Difference and Other Potential Confounders.
Journal: The Journal of rheumatology
Published: March 16, 2021
Complex Machine-Learning Algorithms and Multivariable Logistic Regression on Par in the Prediction of Insufficient Clinical Response to Methotrexate in Rheumatoid Arthritis.
Journal: Journal of personalized medicine
Published: November 30, 2020
Development and Validation of Rheumatoid Arthritis Disease Activity Indices Including HandScan (Optical Spectral Transmission) Scores.
Journal: Arthritis care & research
Published: October 21, 2020
Utility of the HandScan in monitoring disease activity and prediction of clinical response in rheumatoid arthritis patients: an explorative study.
Journal: Rheumatology advances in practice
Published: August 26, 2020
Effect on Costs and Quality-adjusted Life-years of Treat-to-target Treatment Strategies Initiating Methotrexate, or Tocilizumab, or Their Combination in Early Rheumatoid Arthritis.
Journal: The Journal of rheumatology
Published: July 15, 2020
Validation of a Prognostic Multivariable Prediction Model for Insufficient Clinical Response to Methotrexate in Early Rheumatoid Arthritis and Its Clinical Application in Evidencio.
Journal: Rheumatology and therapy
Published: July 14, 2020
Effectiveness and safety over 3 years after the 2-year U-Act-Early trial of the strategies initiating tocilizumab and/or methotrexate.
Journal: Rheumatology (Oxford, England)
Published: July 05, 2019
Effectiveness of Remission Induction Strategies for Early Rheumatoid Arthritis: a Systematic Literature Review.
Journal: Current rheumatology reports
Published: April 25, 2019
Last Updated: 09/26/2026